Navigation Links
Xarelto Lawsuits Filed Contend Wrongful Death and Internal Hemorrhaging Due to Blood Thinner
Date:7/20/2014

Columbus, OH (PRWEB) July 20, 2014

The attorneys at Wright & Schulte LLC have learned through Reuters that almost 10 Xarelto lawsuits have been filed in the United States against Germany-based Bayer AG over its blood-thinning medication. Court records indicate that one of the Xarelto lawsuits was filed on behalf of a Kentucky woman who alleges developing uncontrollable internal bleeding as a result of taking the blood thinner. The Xarelto lawsuit was filed February 24 in the Pennsylvania Court of Common Pleas, Philadelphia County. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) More recently, a Florida woman filed a Xarelto wrongful death complaint in the U.S. District Court, Southern District of Florida that alleges her husband died due to uncontrollable bleeding after taking Xarelto. (Case 9:14cv80831)
[reuters.com/article/2014/06/14/us-bayer-
suit-idUSKBN0EP0HW20140614, June 14, 2014]

Xarelto, generically known as rivaroxaban, is a prescription blood thinner manufactured by Bayer and marketed in the United States by Janssen Pharmaceuticals, a division of Johnson & Johnson. The U.S. Food & Drug Administration (FDA) approved Xarelto for treatment in reducing deep vein thrombosis and pulmonary embolism in patients who had knee or hip replacement surgery and for reducing stroke and blood clot risks in patients with atrial fibrillation.
[fda.gov/NewsEvents/Newsroom/Press
Announcements/ucm326654.htm, November 2, 2012]

According to court documents, a Florida woman filed a Xarelto wrongful death complaint on June 23, 2014, in U.S. District Court, Southern District of Florida that alleges her husband was prescribed Xarelto in January 2012 to treat atrial fibrillation. According to the Xarelto lawsuit, the spouse was hospitalized on June 23, 2012, after suffering a subdural hemorrhage. He underwent a medical procedure in an attempt to stop the bleeding, but died five days later. The Florida woman’s Xarelto lawsuit contends that the defendants, Janssen Research & Development and Bayer, concealed their knowledge to consumers, the general public and the medical community that Xarelto allegedly causes life-threatening irreversible bleeds. The Xarelto lawsuit further contends the defendants did not warn or advise how to intervene and stabilize a patient should a bleed occur. (Case 9:14cv80831)

Court records further show that a Kentucky woman’s Xarelto complaint against Janssen Research & Development and Bayer Corp. alleges she was prescribed the blood thinner in July 2012 to treat atrial fibrillation. In February 2013, she suffered severe internal and gastrointestinal bleeding that required hospitalization in order for doctors to stop the bleeding. The Xarelto complaint further alleges that the defendants were negligent in introducing the drug. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) The complaint was filed a month after the Pennsylvania Supreme Court’s January 21st ruling that pharmaceutical companies in Pennsylvania can be held negligent for marketing or designing drugs that they know or should have known are to dangerous to use.
[pacourts.us/assets/opinions/Supreme/out/J-69AandB-2011mo.pdf?cb=7, January 21, 2014.]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you or your loved one suffered serious internal bleeding or other related complications as a result of using Xarelto, contact the law firm for a free, no-obligation legal consultation. If you're looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029984.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
2. Xarelto is Alleged to Cause Serious and Uncontrolled Internal Bleeding
3. Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
4. AffordRx Now Offering Xarelto Coupon Cards
5. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
6. Federal DePuy ASR Litigation Schedules July Conference to Discuss Lawsuits over Recalled Hip Replacement
7. Nearly 780 Mirena IUD Lawsuits Now Filed in New Jersey Litigation, Bernstein Liebhard LLP Reports
8. As Testosterone Lawsuits Are Filed In The U.S., Canada Warns of Possible Cardiac Risks Associated With Testosterone Medication
9. Stryker Recall Litigation in New Jersey Now Includes More than 2,000 Lawsuits over Rejuvenate, ABG II Metal Hips, Bernstein Liebhard LLP Reports
10. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
11. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... Durham, NC (PRWEB) , ... March 30, 2017 ... ... professionals, will host the live audio conference “ Preventing Hospital Readmissions Through Discharge ... April 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent ...
(Date:3/29/2017)... ... 2017 , ... During the last week of March, Chad Kawa, MD of ... in the local community. , Colon cancer is the second leading cause of ... while it is small, confined and easier to treat. If you are 50 or ...
(Date:3/29/2017)... Diego, CA (PRWEB) , ... March 29, 2017 , ... ... and up to 300,000 people each year develop other types of metastatic brain tumors(3). ... quickly throughout the brain(3). As efforts focus on finding more effective treatment options, the ...
(Date:3/29/2017)... ... 29, 2017 , ... Full Contact K9, an Atlanta-based dog services provider, has ... that assists dog owners in creating legally-enforceable pet trusts for their canine companions. ... step to protect their new companion. Says Evan Dunbar, CEO of Full Contact K9, ...
(Date:3/29/2017)... MD (PRWEB) , ... March 30, 2017 , ... CHARM ... Charm City Run has announced that Mercy Medical Center will serve as the official ... the Mid-Atlantic region. On Sunday, June 25, 2017, thousands of women will walk or ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... EAST HANOVER, N.J. , March 29, 2017 ... and Drug Administration (FDA) has accepted the company,s ... review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen ... refractory (r/r) pediatric and young adult patients with ... first BLA submission by Novartis for a CAR-T. ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets ... Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast" report ... The ... from its current market size in 2016. The Untapped Proton Therapy Market ... 1 Billion USD in 2016. Proton Therapy plays an ...
(Date:3/29/2017)... , March 29, 2017  Zynex (OTCQB: ZYXI), an ... sale of non-invasive medical devices for pain management, stroke ... it will host the Company,s 2016 full-year investor webcast ... Time.) The Company expects to file its ... ...
Breaking Medicine Technology: